Antipsychotic pharmacotherapy and orthostatic hypotension: Identification and management

CNS Drugs

Volumn 25, Issue 8, 2011, Pages 659-671

  Gugger, James J ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

Antipsychotics; Desmopressin; Fludrocortisone; Midodrine; Orthostatic hypotension; Schizophrenia.

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIANGINA PECTORIS AGENT; ARIPIPRAZOLE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORPROMAZINE; CLOZAPINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUDROCORTISONE; FLUPHENAZINE; FLUPHENAZINE DECANOATE; HALOPERIDOL; ILOPERIDONE; LOXAPINE; LURASIDONE; NEUROLEPTIC AGENT; OLANZAPINE; OPIATE; PERPHENAZINE; PHENOTHIAZINE; PHOSPHODIESTERASE V INHIBITOR; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TIOTIXENE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIFLUOPERAZINE; UNINDEXED DRUG; VASODILATOR AGENT; ZIPRASIDONE;

ADD ON THERAPY; ADRENERGIC SYSTEM; ALCOHOL CONSUMPTION; ALCOHOLISM; ANOREXIA; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE; BRAIN PERFUSION; CARBOHYDRATE DIET; CARDIOVASCULAR RISK; CATATONIA; CIRCULATION; COMPRESSION THERAPY; CONGESTIVE HEART FAILURE; DEHYDRATION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIARRHEA; DISEASE PREDISPOSITION; DIZZINESS; DRUG ANTAGONISM; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; EDEMA; EMERGENCY WARD; EXTRAPYRAMIDAL SYMPTOM; FALLING; FEVER; FLUID BALANCE; FLUID INTAKE; FLUID THERAPY; GROUPS BY AGE; HEADACHE; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART PRELOAD; HEART RATE; HEART STROKE VOLUME; HOSPITAL PATIENT; HUMAN; HYPERTENSION; HYPOCALCEMIA; HYPOMAGNESEMIA; HYPOVOLEMIA; INCIDENCE; LEG; LEG SWELLING; LOW DRUG DOSE; MAXIMUM PLASMA CONCENTRATION; MEDICAL HISTORY; METABOLIC SYNDROME X; MIGRAINE; MORTALITY; ORTHOSTATIC BLOOD PRESSURE; ORTHOSTATIC HYPOTENSION; ORTHOSTATIC STRESS; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PATIENT MONITORING; PHYSICAL ACTIVITY; POSITIONAL DIZZINESS; PRESSORECEPTOR; PRIORITY JOURNAL; PSYCHOSIS; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SALT INTAKE; SCHIZOPHRENIA; SEIZURE; SHY DRAGER SYNDROME; SIDE EFFECT; SMOOTH MUSCLE CONTRACTION; STANDING; STROKE; SUDDEN DEATH; SUPINE POSITION; SYNCOPE; SYSTEMIC VASCULAR RESISTANCE; SYSTOLIC BLOOD PRESSURE; THERMAL EXPOSURE; TRANSIENT ISCHEMIC ATTACK; VASOCONSTRICTION; VENOUS RETURN; VISUAL DISORDER; VOMITING; WEAKNESS; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; BLOOD PRESSURE; DRUG INTERACTIONS; DRUG MONITORING; HUMANS; HYPOTENSION, ORTHOSTATIC; PSYCHOTIC DISORDERS; RISK FACTORS;

EID: 79960800406     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.2165/11591710-000000000-00000     Document Type: Review

References (106)

1. Michelsen JW, Meyer JM. Cardiovascular effects of antipsychotics. Expert Rev Neurother 2007; 7: 829-39 (Pubitemid 47037723)
2. Drici MD, Priori S. Cardiovascular risks of atypical antipsychotic drug treatment. Pharmacoepidemiol Drug Saf 2007; 16: 882-90 (Pubitemid 47322588)
3. Casey DE. The relationship of pharmacology to side effects. J Clin Psychiatry 1997; 58 Suppl. 10: 55-62
4. Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353: 1209-23 (Pubitemid 41345943)
5. Stroup TS, Lieberman JA, McEvoy JP, et al. Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study. Am J Psychiatry 2007; 164: 415-27 (Pubitemid 46513155)
6. Stroup TS, Lieberman JA, McEvoy JP, et al. Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. Am J Psychiatry 2006; 163: 611-22 (Pubitemid 44464570)
7. McEvoy JP, Lieberman JA, Stroup TS, et al. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry 2006; 163: 600-10 (Pubitemid 44464569)
8. Stroup TS, Lieberman JA, McEvoy JP, et al. Results of phase 3 of the CATIE schizophrenia trial. Schizophr Res 2009; 107: 1-12
9. Citrome L. Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic. Int J Clin Pract 2009; 63: 1237-48
10. Latuda-(lurasidone hydrochloride): US prescribing information [online]. Marlborough, MA: Sunovion Pharmaceuticals Inc., Oct 2010. Available from URL: http://www.latuda.com/LatudaPrescribingInformation.pdf [Accessed 2011 Apr 20]
11. Citrome L. Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic. Int J Clin Pract 2009; 63: 1762-84
12. Swett Jr C, Cole JO, Hartz SC, et al. Hypotension due to chlorpromazine: relation to cigarette smoking, blood pressure, and dosage. Arch Gen Psychiatry 1977; 34: 661-3 (Pubitemid 8131490)
13. Timdahl K, Carlsson A, Stening G. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms. Hum Psychopharmacol 2007; 22: 315-25 (Pubitemid 47180393)
14. Bishop MP, Gallant DM. Loxapine: a controlled evaluation in chronic schizophrenic patients. Curr Ther Res Clin Exp 1970; 12: 594-7
15. Gershon S, Hekimian LJ, Burdock EI, et al. Antipsychotic properties of loxapine succinate. Curr Ther Res Clin Exp 1970; 12: 280-5
16. Hansen TE, Casey DE, Hoffman WF. Neuroleptic intolerance. Schizophr Bull 1997; 23: 567-82 (Pubitemid 27485968)
17. Mackin P. Cardiac side effects of psychiatric drugs. Hum Psychopharmacol 2008; 23 Suppl. 1: 3-14
18. Simpson GM, Cuculic Z. A double-blind comparison of loxapine succinate and trifluoperazine in newly admitted schizophrenic patients. J Clin Pharmacol 1976; 16: 60-5
19. Weiden PJ, Cutler AJ, Polymeropoulos MH, et al. Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials. J Clin Psychopharmacol 2008; 28 (2 Suppl. 1): S12-9 (Pubitemid 351397672)
20. Zyprexa(olanzapine): US prescribing information [online]. Indianapolis, IN: Eli Lilly and Company, Dec 2010. Available from URL: http://pi.lilly.com/us/ zyprexa-pi.pdf [Accessed 2011 Apr 21]
21. Curry SH. Chlorpromazine: concentrations in plasma, excretion in urine and duration of effect. Proc R Soc Med 1971; 64: 285-9
22. Chandrasena R,Dvorakova D, Lee SI, et al. Intramuscular olanzapine vs. intramuscular short-acting antipsychotics: safety, tolerability and the switch to oral antipsychotic medication in patients with schizophrenia or acute mania. Int J Clin Pract 2009; 63: 1249-58
23. Iserson KV. Parenteral chlorpromazine treatment of migraine. Ann Emerg Med 1983; 12: 756-8 (Pubitemid 14203716)
24. Ritter RM, Davidson DE, Robinson TA. Comparison of injectable haloperidol and chlorpromazine. Am J Psychiatry 1972; 129: 78-81
25. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy: the Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology 1996; 46: 1470
26. Mets TF. Drug-induced orthostatic hypotension in older patients. Drugs Aging 1995; 6: 219-28
27. Scalco MZ, de Almeida OP, Hachul DT, et al. Comparison of risk of orthostatic hypotension in elderly depressed hypertensive women treated with nortriptyline and thiazides versus elderly depressed normotensive women treated with nortriptyline. Am J Cardiol 2000; 85: 1156-8, A9 (Pubitemid 30214270)
28. Ensrud KE, Nevitt MC, Yunis C, et al. Postural hypotension and postural dizziness in elderly women: the study of osteoporotic fractures. The Study of Osteoporotic Fractures Research Group. Arch Intern Med 1992; 152: 1058-64
29. Kaplan NM. Hypotension as a complication of promazine therapy. AMA Arch Intern Med 1959; 103: 219-23
30. Jefferson JW. Atypical manifestations of postural hypotension. Arch Gen Psychiatry 1972; 27: 250-1
31. Rutan GH, Hermanson B, Bild DE, et al. Orthostatic hypotension in older adults: the Cardiovascular Health Study. CHS Collaborative Research Group. Hypertension 1992; 19: 508-19
32. Rosati D. Hypotensive side effects of phenothiazine and their management. Dis Nerv Syst 1964; 25: 366-9
33. Eigenbrodt ML, Rose KM, Couper DJ, et al. Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996. Stroke 2000; 31: 2307-13
34. Masaki KH, Schatz IJ, Burchfiel CM, et al. Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program. Circulation 1998; 98: 2290-5 (Pubitemid 28533848)
35. Rose KM, Eigenbrodt ML, Biga RL, et al. Orthostatic hypotension predicts mortality in middle-aged adults: the Atherosclerosis Risk In Communities (ARIC) Study. Circulation 2006; 114: 630-6 (Pubitemid 44252304)
36. Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009; 360: 225-35
37. Silver H, Kogan H, ZlotogorskiD. Postural hypotension in chronically medicated schizophrenics. J Clin Psychiatry 1990; 51: 459-62
38. Smith JJ, Porth CM, Erickson M. Hemodynamic response to the upright posture. J Clin Pharmacol 1994; 34: 375-86 (Pubitemid 24154140)
39. Westfall TC, Westfall DP. Neurotransmission: the autonomic and somatic motor nervous systems. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman's the pharmacological basis of therapeutics. 11th ed. New York (NY): The McGraw-Hill Companies, Inc., 2006: 137-82
40. Young CR, Bowers Jr MB, Mazure CM. Management of the adverse effects of clozapine. Schizophr Bull 1998; 24: 381-90 (Pubitemid 28378223)
41. Tonkin AL, Wing LM. Effects of age and isolated systolic hypertension on cardiovascular reflexes. J Hypertens 1994; 12: 1083-8 (Pubitemid 24294821)
42. Laitinen T, Niskanen L, Geelen G, et al. Age dependency of cardiovascular autonomic responses to head-up tilt in healthy subjects. J Appl Physiol 2004; 96: 2333-40 (Pubitemid 38678571)
43. Bradley JG, Davis KA. Orthostatic hypotension. Am Fam Physician 2003; 68: 2393-8 (Pubitemid 38031572)
44. Figueroa JJ, Basford JR, Low PA. Preventing and treating orthostatic hypotension: as easy as A, B, C. Cleve Clin J Med 2010; 77: 298-306
45. Freeman R. Current pharmacologic treatment for orthostatic hypotension. Clin Auton Res 2008; 18 Suppl. 1: 14-8 (Pubitemid 351667199)
46. Jordan J. Effect of water drinking on sympathetic nervous activity and blood pressure. Curr Hypertens Rep 2005; 7: 17-20 (Pubitemid 40277786)
47. Jordan J, Shannon JR, Black BK, et al. The pressor response to water drinking in humans: a sympathetic reflex? Circulation 2000; 101: 504-9 (Pubitemid 30080864)
48. Goldstein DS, Robertson D, Esler M, et al. Dysautonomias: clinical disorders of the autonomic nervous system. Ann Intern Med 2002; 137: 753-63 (Pubitemid 35265320)
49. LaWall JS. Treatment of psychotropic-caused orthostatic hypotension. Psychosomatics 1980; 21: 693-4
50. Pirke KM. Central and peripheral noradrenalin regulation in eating disorders. Psychiatry Res 1996; 62: 43-9 (Pubitemid 26153326)
51. Kaufmann H. Treatment of patients with orthostatic hypotension and syncope. Clin Neuropharmacol 2002; 25: 133-41 (Pubitemid 34556422)
52. Friedman JH, Factor SA. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease. Mov Disord 2000; 15: 201-11 (Pubitemid 30167909)
53. Weber MA. Calcium channel antagonists in the treatment of hypertension. Am J Cardiovasc Drugs 2002; 2: 415-31 (Pubitemid 36097822)
54. Kranzler HR, Cardoni A. Sodium chloride treatment of antidepressant- induced orthostatic hypotension. J Clin Psychiatry 1988; 49: 366-8
55. Maskall DD, Lam RW. Midodrine for TCA-induced orthostatic hypotension. J Psychiatry Neurosci 1993; 18: 276-7 (Pubitemid 24018032)
56. Forster HS. Naproxen reversal of nortriptyline-induced orthostatic hypotension [letter]. J Clin Psychiatry 1989; 50: 356 (Pubitemid 19239060)
57. Poon IO, Braun U. High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans. J Clin Pharm Ther 2005; 30: 173-8 (Pubitemid 41583613)
58. Campese VM. Minoxidil: a review of its pharmacological properties and therapeutic use. Drugs 1981; 22: 257-78 (Pubitemid 12166000)
59. Slavachevsky I, Rachmani R, Levi Z, et al. Effect of enalapril and nifedipine on orthostatic hypotension in older hypertensive patients. J Am Geriatr Soc 2000; 48: 807-10 (Pubitemid 30457420)
60. Wong J, Patel RA, Kowey PR. The clinical use of angiotensin-converting enzyme inhibitors. Prog Cardiovasc Dis 2004; 47: 116-30 (Pubitemid 39600946)
61. Thomas M, Malmcrona R, Fillmore S, et al. Haemodynamic effects of morphine in patients with acute myocardial infarction. Br Heart J 1965; 27: 863-75
62. Crawford ME, Moiniche S, Orbaek J, et al. Orthostatic hypotension during postoperative continuous thoracic epidural bupivacaine-morphine in patients undergoing abdominal surgery. Anesth Analg 1996; 83: 1028-32 (Pubitemid 26365417)
63. Chambers JA. The haemodynamic effects of morphine. Arch Emerg Med 1988; 5: 124-5
64. Prisant LM. Phosphodiesterase-5 inhibitors and their hemodynamic effects. Curr Hypertens Rep 2006; 8: 345-51 (Pubitemid 44262929)
65. Chaudhuri KR, Maule S, Thomaides T, et al. Alcohol ingestion lowers supine blood pressure, causes splanchnic vasodilatation and worsens postural hypotension in primary autonomic failure. J Neurol 1994; 241: 145-52 (Pubitemid 24026825)
66. Narkiewicz K, Cooley RL, Somers VK. Alcohol potentiates orthostatic hypotension: implications for alcoholrelated syncope. Circulation 2000; 101: 398-402 (Pubitemid 30067396)
67. Fung HL. Biochemical mechanism of nitroglycerin action and tolerance: is this old mystery solved? Annu Rev Pharmacol Toxicol 2004; 44: 67-85
68. MacMillan LB, Hein L, Smith MS, et al. Central hypotensive effects of the alpha2a-adrenergic receptor subtype. Science 1996; 273: 801-3 (Pubitemid 26271526)
69. Lindqvist A, Jalonen J, Laitinen LA, et al. The effects of midazolam and ephedrine on post-exercise autonomic chronotropic control of the heart in normal subjects. Clin Auton Res 1996; 6: 343-9 (Pubitemid 27019518)
70. van den Berg F, Tulen JH, Boomsma F, et al. Effects of alprazolam and lorazepam on catecholaminergic and cardiovascular activity during supine rest, mental load and orthostatic challenge. Psychopharmacology (Berl) 1996; 128: 21-30 (Pubitemid 26379262)
71. Durrieu G, Senard JM, Tran MA, et al. Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians. Clin Neuropharmacol 1991; 14: 84-90
72. Haapaniemi TH, Kallio MA, Korpelainen JT, et al. Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease. J Neurol 2000; 247: 868-74
73. Munjack DJ. The treatment of phenelzine-induced hypotension with salt tablets: case report. J Clin Psychiatry 1984; 45: 89-90 (Pubitemid 14194570)
74. Console AD. ControllingMAOinhibitor hypotension. Am J Psychiatry 1964; 120: 709-11
75. Robie TR. Controlling monoamine oxidase inhibitor hypotension with 9-alpha-fluoro-hydrocortisone. Am J Psychiatry 1963; 120: 170-1
76. Simonson M. Controlling MAO inhibitor hypotension. Am J Psychiatry 1964; 120: 1118-9
77. Turkka J, Suominen K, Tolonen U, et al. Selegiline diminishes cardiovascular autonomic responses in Parkinson's disease. Neurology 1997; 48: 662-7 (Pubitemid 27120103)
78. Churchyard A, Mathias CJ, Boonkongchuen P, et al. Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease. J Neurol Neurosurg Psychiatry 1997; 63: 228-34 (Pubitemid 27388974)
79. Aronow WS. Treating hypertension in older adults: safety considerations. Drug Saf 2009; 32: 111-8
80. Westfall TC, Westfall DP. Adrenergic agonists and antagonists. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman's the pharmacological basis of therapeutics. 11th ed. New York (NY): The McGraw-Hill Companies, Inc., 2006: 237-96
81. Alexander Jr HE,McCarty K, Giffen MB.Hypotension and cardiopulmonary arrest associated with concurrent haloperidol and propranolol therapy. JAMA 1984; 252: 87-8 (Pubitemid 14086139)
82. Vestal RE, Kornhauser DM, Hollifield JW, et al. Inhibition of propranolol metabolism by chlorpromazine. Clin Pharmacol Ther 1979; 25: 19-24 (Pubitemid 9158769)
83. Seideman P, Grahnen A, Haglund K, et al. Prazosin first dose phenomenon during combined treatment with a beta-adrenoceptor blocker in hypertensive patients. Br J Clin Pharmacol 1982; 13: 865-70 (Pubitemid 13139873)
84. Raj SR, Black BK, Biaggioni I, et al. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more. Circulation 2009; 120: 725-34
85. Freitas J, SantosR, AzevedoE, et al. Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone. ClinAuton Res 2000; 10: 293-9 (Pubitemid 32066011)
86. Fruncillo RJ, Gibbons WJ, Vlasses PH, et al. Severe hypotension associated with concurrent clonidine and antipsychotic medication [letter]. Am J Psychiatry 1985; 142: 274
87. Cantrell MA, Bream-Rouwenhorst HR, Hemerson P, et al. Silodosin for benign prostatic hyperplasia. Ann Pharmacother 2010; 44: 302-10
88. Schwinn DA, Roehrborn CG. Alpha1-adrenoceptor subtypes and lower urinary tract symptoms. Int J Urol 2008; 15: 193-9 (Pubitemid 351316928)
89. Aronowitz JS, Chakos MH, Safferman AZ, et al. Syncope associated with the combination of clozapine and enalapril. J Clin Psychopharmacol 1994; 14: 429-30 (Pubitemid 24378149)
90. White WB. Hypotension with postural syncope secondary to the combination of chlorpromazine and captopril. Arch Intern Med 1986; 146: 1833-4
91. Clozaril(clozapine): US prescribing information [online]. East Hanover, NJ: Novartis Pharmaceuticals Corporation, Dec 2010. Available from URL: http://www.pharma.us. novatis.com/product/pi/pdf/Clozaril.pdf [Accessed 2011 Apr 20]
92. Pae CU, Kim JJ, Lee CU, et al. Rapid versus conventional initiation of quetiapine in the treatment of schizophrenia: a randomized, parallel-group trial. J Clin Psychiatry 2007; 68: 399-405
93. Boidi G, Ferro M. Rapid dose initiation of quetiapine for the treatment of acute schizophrenia and schizoaffective disorder: a randomised, multicentre, parallel-group, open study. Hum Psychopharmacol 2007; 22: 299-306 (Pubitemid 47180391)
94. Smith MA, McCoy R, Hamer-Maansson J, et al. Rapid dose escalation with quetiapine: a pilot study. J Clin Psychopharmacol 2005; 25: 331-5 (Pubitemid 41060252)
95. Baker RW, Kinon BJ, Maguire GA, et al. Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation. J Clin Psychopharmacol 2003; 23: 342-8 (Pubitemid 36951175)
96. Karagianis JL, Dawe IC, Thakur A, et al. Rapid tranquilization with olanzapine in acute psychosis: a case series. J Clin Psychiatry 2001; 62 Suppl. 2: 12-6 (Pubitemid 32154135)
97. Feifel D, Moutier CY, Perry W. Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone. J Clin Psychiatry 2000; 61: 909-11 (Pubitemid 32058004)
98. Chengappa KN, Parepally H, Brar JS, et al. A randomassignment, double-blind, clinical trial of once-vs twicedaily administration of quetiapine fumarate in patients with schizophrenia or schizoaffective disorder: a pilot study. Can J Psychiatry 2003; 48: 187-94 (Pubitemid 36596948)
99. Figueroa C, Brecher M, Hamer-Maansson JE, et al. Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 199-204
100. Testani Jr M. Clozapine-induced orthostatic hypotension treated with fludrocortisone. J Clin Psychiatry 1994; 55: 497-8
101. Schimmer BP, Parker KL. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman's the pharmacological basis of therapeutics. 11th ed. New York (NY): The McGraw-Hill Companies, Inc., 2006: 1587-612
102. Mathias CJ, Fosbraey P, da Costa DF, et al. The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure. Br Med J (Clin Res Ed) 1986; 293: 353-4 (Pubitemid 16043927)
103. Stumpf JL, Mitrzyk B. Management of orthostatic hypotension. Am J Hosp Pharm 1994; 51: 648-60; quiz 697-8 (Pubitemid 24081354)
104. Sarma S, Ward W, O'Brien J, et al. Severe hyponatraemia associated with desmopressin nasal spray to treat clozapine-induced nocturnal enuresis [letter]. Aust N Z J Psychiatry 2005; 39: 949 (Pubitemid 43904464)
105. Castrioto A, Tambasco N, Rossi A, et al. Acute dystonia induced by the combination of midodrine and perphenazine. J Neurol 2008; 255: 767-8
106. Takahashi H. Acute dystonia induced by adding midodrine, a selective alpha 1 agonist, to risperidone in a patient with catatonic schizophrenia. J Neuropsychiatry Clin Neurosci 2000; 12: 285-6 (Pubitemid 30303789)